ORIC Pharmaceuticals, Inc. (ORIC) Expected Move
Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.
ORIC Pharmaceuticals, Inc. (ORIC) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $814.7M, listed on NASDAQ, employing roughly 111 people, carrying a beta of 0.98 to the broader market. ORIC Pharmaceuticals, Inc. Led by Jacob Chacko, public since 2020-04-24.
Snapshot as of Nov 13, 2026.
- Spot Price
- $7.92
- Front DTE
- 35 days
How to read the ORIC implied-range data
The implied range is the one-standard-deviation implied price band at each listed expiration, derived from ATM implied volatility scaled to days-to-expiration. Under lognormal assumptions, roughly 68% of outcomes fall inside that band; 95% fall inside ±2σ; 99.7% inside ±3σ. The empirical equity-return distribution has fatter tails than lognormal, so true tail-outcome frequency is moderately higher than these closed-form numbers suggest.
ORIC expected move and event pricing
Expected move widens with √time: a 5% 30-day move corresponds to roughly a 2.5% 7.5-day move and a 10% 120-day move.
Sizing ORIC structures to the expected move
Iron condors with wings at ±1σ collect the modal-outcome premium; ±1.5σ widens probability of inside-range to ~87% but cuts collected premium roughly in half. Strangles do the inverse trade - they pay against the same lognormal distribution, profiting when realized exceeds implied. Calendar spreads bet on the slope of the term structure rather than the level. ORIC put/call volume ratio currently at 0.13 indicates speculative call flow dominates - look for upside-skewed sentiment. The expected move is the inputs the chain is pricing, not a forecast - realized moves above or below are normal under any distribution.
Learn how expected move is reported and how to read the data →